January 25, 2022 06:57 AM ESTUpdated 07:56 AM
FDA+
Coronavirus

US re­stricts use of two mon­o­clon­al an­ti­bod­ies that don't work against Omi­cron

Zachary Brennan

Senior Editor

Two mon­o­clon­al an­ti­body com­bos from Eli Lil­ly and Re­gen­eron are no longer au­tho­rized in the US, and ship­ments to states have ceased be­cause HHS said …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J takes 340B fight with fed­er­al gov­ern­ment to court

Dan­ish biotech Gubra touts ear­ly weight loss da­ta in hot amylin field

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

New can­cer class heats up as BioN­Tech buys out Chi­na part­ner and its PD-L1/VEGF drug

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times